Papers
1
Total Citations
4
H-Index
1
About
Weilue Chen is a virologist whose work focuses on advancing methodologies for studying viral neutralization, with a particular emphasis on human adenoviruses. Chen’s most notable contribution is the development of a sensitive, high-throughput flow cytometry-based assay for measuring antibody neutralization of human adenovirus type 3, published in 2020. This innovative approach offers a rapid, quantitative, and reproducible alternative to traditional plaque reduction assays, enabling more efficient screening of neutralizing antibodies and facilitating vaccine development and immunological studies. Although early in its citation impact, this work represents a significant technical advancement in adenovirus research, providing a valuable tool for understanding host immune responses and evaluating antiviral therapies. Chen’s research bridges virology and immunology, with potential applications in vaccine efficacy testing and therapeutic antibody development. By streamlining neutralization assays, Chen contributes to the broader effort to combat adenovirus infections, which can cause severe respiratory and ocular diseases, particularly in immunocompromised individuals. This methodological innovation underscores Chen’s commitment to improving experimental precision and throughput in virological research.
Research Focus
Key Achievements
Top Papers
- 1